Hana Študentová

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

Michael J. Morris, Daniel Castellano, Ken Herrmann et al. · The Lancet · 2024 · 189 citations · Full text

Urology, Oncology, Genitourinary Cancer +8

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

Paolo Grassi, Ludovic Doucet, Palma Giglione et al. · PLoS ONE · 2016 · 73 citations · Full text

Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy.

Bohuslav Melichar, Hana Študentová, Hana Kalábová et al. · PubMed · 2014 · 56 citations

Tumor Immunology, Breast Oncology, Cancer Immunosurveillance +14

Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls

Denise Wolrab, Robert Jirásko, Ondřej Peterka et al. · Scientific Reports · 2021 · 37 citations · Full text

Determination of one year stability of lipid plasma profile and comparison of blood collection tubes using UHPSFC/MS and HILIC-UHPLC/MS

Denise Wolrab, Michaela Chocholoušková, Robert Jirásko et al. · Analytica Chimica Acta · 2020 · 30 citations

Lipid Analysis, Year Stability, Medicine +9